We present two different staining protocols for NKG2D ligand (NKG2DL) detection in human primary acute myeloid leukemia (AML) samples. The first approach is based on a fusion protein, able to recognize all known and potentially yet unknown ligands, while the second protocol relies on the addition of multiple anti-NKG2DL antibodies.
Landerer, H., Arnone, M., Wieboldt, R., Goersch, E., Stanger, A. M. P., Konantz, M., Lengerke, C. Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia. J. Vis. Exp. (168), e61803, doi:10.3791/61803 (2021).